<a href=https://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/>Zoya Demidenko</a>: Researcher in Tumor Science
<a href=https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0026126>Zoya Demidenko</a> is a prominent investigator connected with the Division of Cell Stress Biology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Before that, she was employed at the National Institutes of Health and New York Medical College, building a strong background in clinical research.
Demidenko's scientific work spans several pivotal domains, including the PI3K/AKT/mTOR molecular pathway, cellular cycle control, biological aging, and malignancy science. As of now, she has written more than 46 academic articles, which have garnered over 4,100 references a reflection to the impact of her research.
Among her key achievements involves elucidating the mechanisms of cell aging. Her research revealed that when the cell cycle is arrested yet cellular growth continues, the cells experience senescence. Significantly, <a href=https://www.aging-us.com/article/100406/>Zoya Demidenko</a> established that this transition is pharmacologically suppressed using compounds such as rapamycin.
<a href=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026126>Zoya Demidenko</a> has furthermore contributed greatly to cancer treatment research, notably in the domain of selective cell protection a method intended to safeguarding non-cancerous tissue from cytotoxic treatment whilst leaving malignant cells susceptible. This strategy carries significant promise for lowering the adverse effects of cancer treatment.
Throughout her professional journey, Demidenko has collaborated with prominent scientists worldwide, such as Dr. Mikhail Blagosklonny. Her research can be found in top-tier journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Possessing an h-index of 33, <a href=https://www.benthamdirect.com/content/journals/cpd/22/16>Zoya Demidenko</a> ranks as a highly impactful contributor in current oncological research, with her findings keep to shape our knowledge of the way cells grow old, resist therapy, and how cancer may be more successfully treated.
https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0026126
|
